跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
張 詩鑫
教授
,
家庭醫學科
主治醫師
,
臺北醫學大學附設醫院
https://orcid.org/0000-0001-7705-884X
電子郵件
sschang0529
tmu.edu
tw
h-index
2703
引文
29
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1999
2024
每年研究成果
概覽
指紋
網路
專案
(8)
研究成果
(90)
資料集
(11)
類似的個人檔案
(6)
指紋
查看啟用 Shy-Shin Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Meta-Analysis
100%
Emergency Department
91%
Sepsis
85%
Chronic Kidney Disease
55%
C Reactive Protein
54%
Systematic Review
53%
Cohort Analysis
50%
Odds Ratio
49%
Procalcitonin
43%
Malignant Neoplasm
40%
Diagnosis
37%
Bacterial Infection
37%
End Stage Liver Disease
37%
Disease
31%
Observational Study
30%
Metabolic Syndrome
30%
Myocardial Infarction
29%
Preventive Medicine
27%
Maturity Onset Diabetes of the Young
27%
Hazard Ratio
27%
Bisphosphonate
25%
Bone Necrosis
25%
4 Iodo 2,5 Dimethoxyamphetamine
25%
Osteoporosis
25%
Health Care
25%
Proportional Hazards Model
20%
Medical Examination
20%
Diabetes Mellitus
19%
Leukocyte
17%
Obesity
17%
Apoplexy
17%
Cardiovascular Disease
16%
Body Mass Index
16%
Logistic Regression Analysis
15%
Pediatrics
15%
Risk Stratification
15%
Troponin I
15%
Retrospective Study
15%
Bloodstream Infection
15%
Kidney Function
15%
Retrospective Cohort Study
15%
Liver Cirrhosis
15%
Cohort Effect
15%
Electronic Patient Record
14%
Transient Elastography
14%
Biological Marker
13%
Intensive Care Unit
13%
Fungemia
12%
Leukocytosis
12%
Dipeptidyl Peptidase-4 Inhibitor
12%
Nursing and Health Professions
Meta Analysis
100%
Emergency Ward
85%
Procalcitonin
83%
Sepsis
77%
Chronic Kidney Failure
76%
C Reactive Protein
75%
Bacterial Infection
75%
Systematic Review
62%
Confidence Interval
52%
Receiver Operating Characteristic
44%
Cohort Analysis
31%
Heart Infarction
29%
Diagnosis
28%
Odds Ratio
26%
Metabolic Syndrome X
26%
Diagnostic Value
24%
Obesity
23%
Body Mass
23%
Palliative Therapy
20%
Medical Examination
17%
Cardiovascular Disease
17%
Leukocyte Count
16%
Medline
16%
Biological Marker
15%
Body Composition
15%
Infection
15%
Hazard Ratio
15%
Liver Cirrhosis
15%
Decision Trees
14%
Artificial Intelligence
14%
University Hospital
14%
Liver Stiffness
14%
Transient Elastography
14%
Logistic Regression Analysis
13%
Intensive Care Unit
13%
Area under the Curve
13%
Disease
13%
D Dimer
12%
Artificial Respiration
12%
Paraquat Poisoning
12%
Distress Syndrome
12%
Typical Antipsychotic
12%
Autoimmune Disease
12%
Leukocytosis
12%
Troponin I
12%
Multiplex Polymerase Chain Reaction
12%
Fungemia
12%
Heart Failure
12%
Bacteremia
12%
Interleukin 6
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
86%
Sepsis
81%
Chronic Kidney Failure
63%
C Reactive Protein
61%
Tuberculosis
50%
Observational Study
44%
Malignant Neoplasm
43%
Disease
41%
Quinolone Derivative
40%
End Stage Liver Disease
37%
Procalcitonin
37%
Typical Antipsychotic
37%
Toxic Injury
37%
Statin (Protein)
30%
Heart Infarction
29%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
26%
Bone Necrosis
25%
Bisphosphonic Acid Derivative
25%
Community Acquired Pneumonia
25%
Nicorandil
25%
Infection
24%
Antibiotic Agent
19%
Sarcopenia
19%
Tree
18%
Cardiovascular Disease
18%
Adverse Event
18%
Diabetes Mellitus
17%
Urinary Tract Infection
17%
Poison Control Centers
17%
Bacterial Infection
16%
Mortality Rate
16%
Retrospective Study
15%
Randomized Controlled Trial
15%
Comorbidity
15%
Digestive System Perforation
15%
Non Insulin Dependent Diabetes Mellitus
15%
Macrolide
15%
Intestine Flora
14%
Physical Disease by Body Function
14%
Abdominal Pain
13%
Ulcer
13%
Symptom
13%
Mouse
12%
D Dimer
12%
Senescence Accelerated Mouse
12%
Skin Ulcer
12%
Sacroiliitis
12%
Hypokalemia
12%
Survival Prediction
12%
Metaldehyde
12%
